Acute lymphoblastic leukemia in a patient with pituitary dwarfism under treatment with growth hormone

Acta Paediatrica Japonica; Overseas Edition
T HaraT Akabane

Abstract

An 18-year-old male with pituitary dwarfism, who had been on replacement of growth hormone (GH) and thyroxine for 3.5 years, developed acute lymphoblastic leukemia (ALL). The GH replacement was discontinued, and he was treated with a conventional protocol for ALL. A complete remission was obtained after 10 weeks. Maintenance chemotherapy was given with reduced doses (1/4 to 1/2) of cytotoxic drugs. The platelet count soon reached 200,000/microL, but the hemoglobin level and white blood cell count improved only slowly, reaching 10.0 g/dL and 1,500/microL, respectively, after five months. He has been in complete remission with a hypocellular bone marrow for nearly 15 months. Since GH can stimulate the proliferation of some normal and leukemic hemato-lymphoid cells, the slow remission induction and the prolonged anemia and leukocytopenia after remission, may have been related to the absence of GH in this patient.

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D W GoldeC H Li
Oct 1, 1973·Experimental Cell Research·L S DesaiG E Foley
Jan 1, 1970·Annual Review of Medicine·R L CapizziR E Handschumacher

❮ Previous
Next ❯

Citations

Apr 15, 2008·Trends in Endocrinology and Metabolism : TEM·P Jenkins
Apr 1, 1995·Acta Paediatrica Japonica; Overseas Edition·S InadaM Eguchi
Oct 1, 1993·European Journal of Pediatrics·T HasegawaY Morikawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.